- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
High-Potency Statins Found Most Effective in Lowering Bad Cholesterol: Study - Video
Overview
New research published in Trends in Cardiovascular Medicine emphasizes the importance of aggressively lowering LDL cholesterol with high-dose statins to prevent and treat cardiovascular disease. In an invited editorial, experts from Florida Atlantic University’s Schmidt College of Medicine argue that potent statins like rosuvastatin and atorvastatin should be used as first-line pharmacologic therapies, alongside lifestyle interventions, to significantly reduce heart attack and stroke risks.
LDL, or low-density lipoprotein cholesterol, commonly known as "bad" cholesterol, is a major contributor to clogged arteries and cardiovascular events. Researchers analyzed a comprehensive body of randomized trial data and concluded that high-potency statins have the “strongest and most consistent body of evidence” for both prevention and treatment—across genders and age groups.
The authors, including senior author Dr. Charles H. Hennekens, highlighted the importance of starting treatment with maximum statin doses and reducing only if necessary. “Practicing cardiologists may wish to consider that all adjunctive drug therapies to therapeutic lifestyle changes should be added only after achieving maximal doses of statins,” said Hennekens.
While statins remain central, the editorial also underscores the continued value of lifestyle changes such as quitting smoking, maintaining a healthy weight, managing blood pressure, increasing physical activity, and limiting alcohol intake. However, many high-risk individuals remain underdiagnosed and undertreated.
The authors offered cautious support for adjunctive therapies like ezetimibe and evolocumab, noting these may benefit only select high-risk patients who don't reach LDL goals with statins alone. Similarly, they acknowledged mixed findings around omega-3 fatty acids, with icosapent ethyl being the only formulation to show significant benefit in modern trials such as REDUCE-IT.
In conclusion, the researchers advocate a prevention-first approach.
Reference: John Dunn, Charles H. Hennekens. Low density lipoprotein (LDL) and beyond in the treatment and prevention of cardiovascular disease. Trends in Cardiovascular Medicine, 2025; DOI: 10.1016/j.tcm.2025.07.005